Perrigo Company Shareholders Encouraged to Join Class Action Against Misleading Practices
Overview
Perrigo Company, a prominent provider of over-the-counter health and wellness products, has come under scrutiny as shareholders report significant losses attributed to misleading information regarding the company's infant formula division. The legal firm Robbins LLP has stepped forward to remind investors who have suffered during the specific class action period—from February 27, 2024, to November 4, 2025—to consider joining the lawsuit aimed at holding the company accountable for potential misrepresentation of its financial health.
Class Action Details
The class action, initiated by Robbins LLP, represents all investors who acquired Perrigo securities during the specified timeframe. Allegations assert that the company failed to disclose critical issues concerning its infant formula business, acquired from Nestlé. The lawsuit claims that Perrigo's management did not reveal substantial underinvestment in maintenance, operational enhancements, and essential repairs necessary for this branch of the business.
Furthermore, it is alleged that Perrigo had to incur significant capital and operational expenses that surpassed what was publicly communicated to the market. Reports indicate that manufacturing deficiencies within the facilities handling the infant formula further compounded these issues. As a direct consequence of these undisclosed failures, the financial results reported by Perrigo, including earnings and cash flow metrics, were significantly overstated.
Recent Developments
The situation escalated on November 5, 2025, when Perrigo announced it had drastically lowered its fiscal outlook for 2025 amidst disappointing financial results from the third quarter. This announcement highlighted adverse trends within the infant formula market dynamics. As a result, Perrigo is now conducting a strategic review of its operations in this sector, reassessing its previous investment strategy amounting to $240 million. Following this news, Perrigo's share price plunged by $5.09, representing a staggering 25.2% drop, closing at $15.10 per share.
What Should Shareholders Do?
Shareholders who experienced losses due to Perrigo's actions have until January 16, 2026, to submit their information to serve as lead plaintiffs in the class action. A lead plaintiff acts on behalf of other class members in guiding the litigation process. While participation is not mandatory for potential recovery, those choosing not to take action can remain as absent class members.
Robbins LLP emphasizes that their representation operates on a contingency fee basis, meaning shareholders will not incur out-of-pocket expenses during the litigation. The firm has a solid reputation in shareholder rights, dedicated to ensuring adequate recovery for investors and responsible corporate governance.
About Robbins LLP
Founded in 2002, Robbins LLP has emerged as a frontrunner in advocating for shareholder rights, assisting investors in recuperating losses and enforcing accountability among corporate executives. Their comprehensive legal expertise has facilitated numerous successful recoveries in securities class actions. Investors interested in staying informed about the progress of the Perrigo class action are encouraged to register via Stock Watch for timely notifications and updates.
If you believe you qualify for participation in this class action, Robbins LLP invites you to reach out by filling out an online form, or contacting attorney Aaron Dumas, Jr., directly at (800) 350-6003 for more information.
With significant implications for Perrigo shareholders, this ongoing class action underlines the critical importance of transparency and integrity within corporate communications. As the proceedings develop, affected shareholders are advised to remain engaged and informed about their rights and potential pathways for recovery.